Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Apr 4;14(1):48.
doi: 10.1186/s13195-022-00991-z.

Sex differences in neuropsychiatric symptoms in Alzheimer's disease dementia: a meta-analysis

Affiliations
Review

Sex differences in neuropsychiatric symptoms in Alzheimer's disease dementia: a meta-analysis

Willem S Eikelboom et al. Alzheimers Res Ther. .

Abstract

Background: Neuropsychiatric symptoms (NPS) are common in individuals with Alzheimer's disease (AD) dementia, but substantial heterogeneity exists in the manifestation of NPS. Sex differences may explain this clinical variability. We aimed to investigate the sex differences in the prevalence and severity of NPS in AD dementia.

Methods: Literature searches were conducted in Embase, MEDLINE/PubMed, Web of Science Core Collection, Cochrane Central Register of Controlled Trials, PsycINFO, and Google Scholar from inception to February 2021. Study selection, data extraction, and quality assessment were conducted in duplicate. Effect sizes were calculated as odds ratios (OR) for NPS prevalence and Hedges' g for NPS severity. Data were pooled using random-effects models. Sources of heterogeneity were examined using meta-regression analyses.

Results: Sixty-two studies were eligible representing 21,554 patients (61.2% females). The majority of the included studies had an overall rating of fair quality (71.0%), with ten studies of good quality (16.1%) and eight studies of poor quality (12.9%). There was no sex difference in the presence of any NPS (k = 4, OR = 1.35 [95% confidence interval 0.78, 2.35]) and overall NPS severity (k = 13, g = 0.04 [- 0.04, 0.12]). Regarding specific symptoms, female sex was associated with more prevalent depressive symptoms (k = 20, OR = 1.60 [1.28, 1.98]), psychotic symptoms (general psychosis k = 4, OR = 1.62 [1.12, 2.33]; delusions k = 12, OR = 1.56 [1.28, 1.89]), and aberrant motor behavior (k = 6, OR = 1.47 [1.09, 1.98]). In addition, female sex was related to more severe depressive symptoms (k = 16, g = 0.24 [0.14, 0.34]), delusions (k = 10, g = 0.19 [0.04, 0.34]), and aberrant motor behavior (k = 9, g = 0.17 [0.08, 0.26]), while apathy was more severe among males compared to females (k = 11, g = - 0.10 [- 0.18, - 0.01]). There was no association between sex and the prevalence and severity of agitation, anxiety, disinhibition, eating behavior, euphoria, hallucinations, irritability, and sleep disturbances. Meta-regression analyses revealed no consistent association between the effect sizes across studies and method of NPS assessment and demographic and clinical characteristics.

Discussion: Female sex was associated with a higher prevalence and greater severity of several specific NPS, while male sex was associated with more severe apathy. While more research is needed into factors underlying these sex differences, our findings may guide tailored treatment approaches of NPS in AD dementia.

Keywords: Alzheimer’s disease; Behavioral and psychological symptoms of dementia; Behavioral symptoms; Meta-analysis; Neuropsychiatry; Sex.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
PRISMA flow diagram of the literature search. Note: created with BioRender.com
Fig. 2
Fig. 2
Forest plots for the prevalence of any NPS and severity of NPS total scores. Abbreviations: AD, Alzheimer’s disease; NPS, neuropsychiatric symptoms
Fig. 3
Fig. 3
Forest plots for the prevalence of specific neuropsychiatric symptoms. Abbreviations: AD, Alzheimer’s disease
Fig. 4
Fig. 4
Forest plots for the severity of specific neuropsychiatric symptoms. Abbreviations: AD, Alzheimer’s disease
Fig. 5
Fig. 5
Funnel plots for the prevalence of neuropsychiatric symptoms. Abbreviations: AMB, aberrant motor behavior; NPS, neuropsychiatric symptoms
Fig. 6
Fig. 6
Funnel plots for the severity of neuropsychiatric symptoms. Abbreviations: AMB, aberrant motor behavior; NPS, neuropsychiatric symptoms

References

    1. Eikelboom WS, van den Berg E, Singleton E, Baart SJ, Coesmans M, Leeuwis AE, et al. Neuropsychiatric and cognitive symptoms across the Alzheimer’s disease clinical spectrum: cross-sectional and longitudinal associations. Neurolog. 2021;97:e1276–e1287. - PMC - PubMed
    1. Garre-Olmo J, López-Pousa S, Vilalta-Franch J, de Fracia BM, Bulbena VA. Grouping and trajectories of neuropsychiatric symptoms in patients with Alzheimer’s disease. Part II: two-year patient trajectories. J Alzheimers Dis. 2010;22:1169–1180. - PubMed
    1. Nebel RA, Aggarwal N, Barnes LL, Gallagher A, Goldstein JM, Kantarci K, et al. Understanding the impact of sex and gender in Alzheimer’s disease: a call to action. Alzheimers Dement. 2018;14:1171–1183. - PMC - PubMed
    1. Clayton JA, Tannenbaum C. Reporting sex, gender, or both in clinical research? JAMA. 2016;316:1863–1864. - PubMed
    1. Alzheimer’s Association 2021 Alzheimer’s disease facts and figures. Alzheimers Dement. 2021;17(3):327–406. - PubMed